6-Chloro-2,3,4,5-tetrafluorobenzoic acid, 95.0%, 10g

7-Methoxy-2,3-dihydro-1H-inden-1-amine, 95.0%, 1g

(Z)-N-(1-(4-Bromophenyl)-1-chloro-3-oxo-3-(piperidin-1-yl)prop-1-en-2-yl)benzamide, 95%, 250mg

(R)-1-(2-FLUOROPYRIDIN-4-YL)ETHANAMINE HCL, 95.0%, 100mg

2-(3-Chloro-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 5g

4-Chloro-1-(4-methoxybenzyl)-1H-imidazo[4,5-c]pyridine-2(3H)-thione, 95+%, 100mg

3-[3-(4-Methoxy-phenyl)-[1,2,4]oxadiazol-5-yl]-propionic acid, 1g

2-piperidinylacetonitrile, 95.0%, 1g

3-IODO-5-METHOXY-1-METHYL-1H-INDOLE, 97.0%, 250mg

tert-Butyl (1-bromonaphthalen-2-yl)carbamate, 97%, 1g

(S)-2-Amino-2-(4-chlorophenyl)ethanol, 95.0%, 1g

9-Bromo-10-(naphthalen-1-yl)anthracene, 95.0%, 5g

Colonne HPLC NUCLEODUR® 300-5 C4 ec, 250 mm, 4,6 mm, 1 pièce(s)